YONIS MUDEY: Open Payments
NPI 1790048767 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 9 payments from 6 companies in 2025. Trend: 2023 $119 · 2024 $542 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $220 |
| Teva Pharmaceuticals USA, Inc. | 2 | $163 |
| Alkermes, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: COBENFY, UZEDY, LYBALVI, FANAPT, INGREZZA, Qelbree.
Industry payments across CA — which companies pay providers there.
